• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Livin 通过调节 JMJD6 促进组蛋白 H2A.X 从而促进结肠癌进展。

Livin promotes colon cancer progression by regulation of H2A.X via JMJD6.

机构信息

The Six Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

The Six Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

出版信息

Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22.

DOI:10.1016/j.lfs.2019.116788
PMID:31445935
Abstract

Livin is an important member of the human inhibitor of apoptosis proteins (IAPs) family. IAPs are proteins with antiapoptotic abilities, and their functions are different from the Bcl-2 (B-cell lymphoma-2) family proteins. However, the precise role of Livin in colon cancer progression remains unclear. The purpose of this study is to assess the effect of overexpression Livin in colon cancer cells and to examine its molecular mechanism. We demonstrated that Livin induced a colon cancer phenotype, including proliferation and migration, by regulating H2A.X (histone family 2A variant (H2AX) phosphorylated on the 39th serine site). We elucidated that Livin degraded Jumonji-C domain-containing 6 protein (JMJD6), which was mediated by the proteasome murine double minute 2 (MDM2), thereby regulating H2A.X. Above all, the overexpression of JMJD6 recovered H2A.X in colon cancer cells with a high level of Livin, thus inhibiting colon cancer malignancy progression. These results reveal a previously unrecognized role for Livin in regulating the tumor-initiating capacity in colon cancer and provide a novel treatment strategy in cancer via the interruption of H2A.X function and the interaction between H2A.X and JMJD6.

摘要

Livin 是人类凋亡抑制蛋白(IAPs)家族的重要成员。IAPs 是具有抗凋亡能力的蛋白质,其功能与 Bcl-2(B 细胞淋巴瘤-2)家族蛋白不同。然而,Livin 在结肠癌进展中的确切作用尚不清楚。本研究旨在评估 Livin 在结肠癌细胞中的过表达效应,并研究其分子机制。我们证明 Livin 通过调节 H2A.X(第 39 位丝氨酸位点磷酸化的组蛋白家族 2A 变体(H2AX))诱导结肠癌表型,包括增殖和迁移。我们阐明 Livin 降解了包含 Jumonji-C 结构域的 6 蛋白(JMJD6),这是由蛋白酶体鼠双微体 2(MDM2)介导的,从而调节 H2A.X。最重要的是,JMJD6 的过表达恢复了 Livin 高水平的结肠癌细胞中的 H2A.X,从而抑制了结肠癌的恶性进展。这些结果揭示了 Livin 在调节结肠癌起始能力方面的先前未被认识的作用,并通过中断 H2A.X 功能和 H2A.X 与 JMJD6 之间的相互作用提供了一种新的癌症治疗策略。

相似文献

1
Livin promotes colon cancer progression by regulation of H2A.X via JMJD6.Livin 通过调节 JMJD6 促进组蛋白 H2A.X 从而促进结肠癌进展。
Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22.
2
JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.JMJD6 通过一种新型的酪氨酸激酶活性调节三阴性乳腺癌细胞中的组蛋白 H2A.X 磷酸化并促进自噬。
Oncogene. 2019 Feb;38(7):980-997. doi: 10.1038/s41388-018-0466-y. Epub 2018 Sep 5.
3
KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.KRas-ERK 信号通路通过调节 JMJD6 介导的 H2A.X 酪氨酸 39 位磷酸化促进葡萄膜黑色素瘤的发生和维持。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4257-4265. doi: 10.1080/21691401.2019.1673764.
4
siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.靶向 Livin 的 siRNA 可降低结肠癌异种移植模型中的肿瘤。
World J Gastroenterol. 2011 May 28;17(20):2563-71. doi: 10.3748/wjg.v17.i20.2563.
5
Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.抗凋亡因子Livin的上调促成结肠癌细胞对顺铂的耐药性。
Tumour Biol. 2013 Apr;34(2):683-93. doi: 10.1007/s13277-012-0596-8. Epub 2012 Nov 28.
6
Livin gene plays a role in drug resistance of colon cancer cells.Livin 基因在结肠癌耐药细胞中起作用。
Clin Biochem. 2010 May;43(7-8):655-60. doi: 10.1016/j.clinbiochem.2010.02.004. Epub 2010 Feb 18.
7
Research progress on Livin protein: an inhibitor of apoptosis.凋亡抑制蛋白 Livin 的研究进展。
Mol Cell Biochem. 2011 Nov;357(1-2):39-45. doi: 10.1007/s11010-011-0873-7. Epub 2011 May 27.
8
JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.JMJD6 通过羟基化作用负向调控 p53 促进结直肠癌发生。
PLoS Biol. 2014 Mar 25;12(3):e1001819. doi: 10.1371/journal.pbio.1001819. eCollection 2014 Mar.
9
Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.Livin 通过诱导上皮-间充质转化和激活 AKT 信号通路促进乳腺癌的进展。
Cell Signal. 2013 Jun;25(6):1413-22. doi: 10.1016/j.cellsig.2013.03.012. Epub 2013 Mar 22.
10
Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.Livin 通过 NF-κB 介导 DU-145 细胞系中的肿瘤细胞侵袭。
Oncol Rep. 2012 Jun;27(6):2010-6. doi: 10.3892/or.2012.1730. Epub 2012 Mar 15.

引用本文的文献

1
Demystifying the Role of Histone Demethylases in Colorectal Cancer: Mechanisms and Therapeutic Opportunities.揭开组蛋白去甲基化酶在结直肠癌中的作用:机制与治疗机遇
Curr Issues Mol Biol. 2025 Apr 9;47(4):267. doi: 10.3390/cimb47040267.
2
HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis.HIST3H2A 通过抑制细胞坏死性凋亡促进前列腺癌的进展。
BMC Cancer. 2024 Apr 29;24(1):544. doi: 10.1186/s12885-024-12308-4.
3
Livin expression promotes keratinocyte release of inflammatory mediators in psoriasis.
Livin 表达促进银屑病角质形成细胞释放炎症介质。
Skin Res Technol. 2024 Feb;30(2):e13603. doi: 10.1111/srt.13603.
4
JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma.JMJD6 作为一种致癌基因,与食管鳞状细胞癌的不良预后相关。
BMC Cancer. 2023 Jul 24;23(1):696. doi: 10.1186/s12885-023-11171-z.
5
RNA-seq reveals novel mechanistic targets of Livin in bladder cancer.RNA-seq 揭示 Livin 在膀胱癌中的新型作用机制靶点。
BMC Urol. 2023 Feb 28;23(1):26. doi: 10.1186/s12894-023-01194-w.
6
H2AFX might be a prognostic biomarker for hepatocellular carcinoma.H2AFX 可能是肝细胞癌的预后生物标志物。
Cancer Rep (Hoboken). 2023 Jan;6(1):e1684. doi: 10.1002/cnr2.1684. Epub 2022 Jul 29.
7
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.表观遗传修饰因子 JMJD6 在肿瘤发生发展和免疫调节中的作用。
Front Immunol. 2022 Mar 14;13:859893. doi: 10.3389/fimmu.2022.859893. eCollection 2022.
8
Akt regulates RSK2 to alter phosphorylation level of H2A.X in breast cancer.在乳腺癌中,Akt调节RSK2以改变H2A.X的磷酸化水平。
Oncol Lett. 2021 Mar;21(3):187. doi: 10.3892/ol.2021.12448. Epub 2021 Jan 6.
9
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.甲基化驱动基因被鉴定为甲状腺癌的新型预后指标。
Front Genet. 2020 Mar 31;11:294. doi: 10.3389/fgene.2020.00294. eCollection 2020.